HIV and hepatitis B virus: options for managing coinfection.
At the International AIDS Society-USA course in New York in October 2002, Douglas T. Dieterich, MD, presented the case history of a patient coinfected with HIV and hepatitis B virus (HBV). HBV infection in patients with HIV is associated with worse prognosis for HBV disease than in patients without HIV and complicates management of both diseases. However, newer treatment options for chronic HBV infection increase the potential for successful management.
Dieterich
Douglas T
DT
Mt Sinai School of Medicine, New York, NY, USA.
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D015897:Comorbidity; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019344:Lactic Acid / Q000097:blood; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D000068698:Tenofovir
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D019259:Lamivudine; D019344:Lactic Acid; C053001:adefovir; D000068698:Tenofovir; D000225:Adenine